One of the most popular events of the week, Rheumatology Roundup: Highlights From the 2017 ACR/ARHP Annual Meeting, will help wrap up this year’s meeting. The hour-long session will take place at 7:30 am Wednesday in Hall B1 and again feature John J. Cush, MD,…
On Saturday, the ACR Board of Directors met to discuss current and future initiatives impacting its 9,500 members. Here is a summary of the meeting: Increasing Access to High-Quality Education: Innovation in education and global awareness of rheumatology were prominent themes. ACR Beyond, a new…
The 2017 Year in Review on Sunday provided a quick overview of the best of basic science and clinical research papers from the past year. Basic science presenter Richard M. Pope, MD, Solovy/Arthritis Research Society Professor and Professor of Rheumatology at the Northwestern University Feinberg…
A universal influenza vaccine? The next big pandemic? What can we expect from the current presidential administration in dealing with emerging or re-emerging infectious disease? Opening Lecture speaker Anthony S. Fauci, MD, explained that while we may not be able to predict the future, the…
A Tuesday morning session will review the preliminary results of the 2016-2017 ACR Update on Rheumatoid Arthritis Disease Activity Measures and 2016-2017 ACR Rheumatoid Arthritis Functional Status Measures. Presenters will discuss the implications and impact of these new recommendations on researchers, clinicians, and healthcare policymakers.…
Many members of the medical community say it is possible to have too much of a good thing. Across all specialties, clinicians and researchers alike suffer from what some call “analysis paralysis” or “big data overload.” “We have an extraordinary amount of knowledge and an…
Discontinuing methotrexate (MTX) for two weeks after vaccination improves the immunogenicity of a seasonal influenza vaccine in patients with rheumatoid arthritis (RA) on a stable dose of MTX without meaningfully increasing disease activity, reported a researcher from South Korea during Sunday morning’s Plenary Session I. Jin…
A Tuesday ACR/ARHP combined session, Phenotyping Hip & Knee OA: Toward Better Clinical Care & Patient Outcomes, will explore emerging science on osteoarthritis phenotypes and how further understanding of the different phenotypes might improve clinical care for osteoarthritis patients. Ali Mobasheri, PhD, Professor of Musculoskeletal…
The ACR is about to release its first-ever guideline for the management of psoriatic arthritis (PsA). Written in conjunction with the National Psoriasis Foundation (NPF), the guideline is designed for rheumatologists, but also will be helpful for dermatologists, primary care providers, and other healthcare professionals…
The ACR is collaborating with the European League Against Rheumatism (EULAR) to develop new classification criteria for systemic lupus erythematosus (SLE). SLE is challenging to diagnose and treat, with an array of symptoms and signs that are not specific to the disease. Additionally, SLE is…